NASDAQ · Medical - Healthcare Information Services

PGNY (PGNY) Stock

$30.89 -2.22% NASDAQ: PGNY Healthcare

Valuation

MetricValue
Price$30.89
Market Cap$2.42B
P/E Ratio34.94
P/B Ratio4.75
P/S Ratio1.63
EPS (TTM)$0.65
52-Week High$32.69
52-Week Low$16.10
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE14.94%
ROA9.12%
ROCE16.47%
Gross Margin24.11%
Operating Margin7.46%
Net Margin5.23%
Debt/Equity0.06
Current Ratio2.73

Annual Financials (USD)

Metric20212022202320242025
Revenue$501.0M$787.0M$1.1B$1.2B$1.3B
Operating Profit$32.0M$23.0M$62.0M$67.0M$85.0M
Net Profit$66.0M$30.0M$62.0M$54.0M$59.0M
EPS$0.66$0.30$0.62$0.57$0.65
Op Margin6.5%3.0%5.7%5.8%6.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$358.0M$543.0M$757.0M$607.0M$742.0M
Total Liabilities$106.0M$166.0M$203.0M$185.0M$226.0M
Cash$91.0M$120.0M$97.0M$162.0M$112.0M
Borrowings$9.0M$8.0M$19.0M$19.0M$28.0M

Latest News

PGNY: Lowering target price to $35.00 Argus Research · Jul 22, 2026 Progyny COO Cummings Sells 3,437 Shares for $109,000 -- Here's What That Means for Investors Motley Fool · Jul 19, 2026 1 Cash-Producing Stock with Competitive Advantages and 2 Facing Challenges StockStory · Jul 17, 2026 Progyny (PGNY) Stock May Be 50% Undervalued On Fresh Analyst Upgrades Simply Wall St. · Jul 16, 2026 Does Rising Analyst Optimism On June Trends Reframe Progyny’s (PGNY) Employer-Demand Story? Simply Wall St. · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$26.0M$80.0M$189.0M$179.0M$210.0M
Investing Cash Flow$7.0M$-47.0M$-204.0M$190.0M$-177.0M
Financing Cash Flow$-18.0M$-12.0M$-17.0M$-312.0M$-101.0M
Net Cash Flow$21.0M$29.0M$-23.0M$65.0M$-48.0M
Free Cash Flow$24.0M$77.0M$185.0M$174.0M$192.0M

Valuation & Return Ratios

MetricValue
PEG Ratio453.69
EV / EBITDA17.24
FCF Yield8.60%
Quick Ratio2.13
Interest Coverage—
Return 1Y36.42%
Return 3Y-21.51%
Return 5Y-44.61%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALVOAlvotech $3.16 +3.10% -10.76 $1.07B 0.00%
GDRX $3.12 +2.30% 28.44 $1.08B 0.00%
OMCL $37.15 -1.33% 99.32 $1.69B 0.00%
OMDA $20.18 -1.61% -71.91 $1.20B 0.00%
PHR $11.44 +1.24% 229.25 $707.13M 0.00%

About PGNY

PGNY stock trades at $30.89 with a market capitalization of $2.42B. The stock is valued at a price-to-earnings (P/E) ratio of 34.94, price-to-book of 4.75, price-to-sales of 1.63. Over the past 52 weeks the stock has ranged between $16.10 and $32.69, and currently trades 5.5% below its 52-week high.

On profitability, PGNY generates a return on equity (ROE) of 14.94%, above the typical market average, return on capital employed of 16.47%, an operating margin of 7.46%, a net profit margin of 5.23%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides